Rep. Michael Rulli

Contact

Capitol Office

2082 Rayburn House Office Building

Washington, DC 20515

(202) 225-5705

District

Ohio – 6th District

Ohio – District 6

Subcommittees (3)

7 Updates

Health

Energy

1 Update

Oversight & Investigations

Ohio – District 6

Contact

Capitol Office

2082 Rayburn House Office Building

Washington, DC 20515

(202) 225-5705

Subcommittees (3)

7 Updates

Health

Energy

1 Update

Oversight & Investigations

District

Ohio – District 6

News & Announcements

Jun 25, 2026

Press Release

O&I Subcommittee Holds Hearing with State Medicaid Directors as Part of Committee’s Extensive Probe into Medicaid Programs Nationwide

WASHINGTON, D.C. – Today, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, led a hearing titled State Medicaid Program Integrity: Examining Fraud Risks and Oversight Deficiencies.

“Let me be clear: fraud is not isolated to these states. As we discussed in two previous hearings before this Subcommittee, Medicaid fraud is a real problem. It happens in every single state, red and blue, and has been harming patients and draining taxpayer resources for decades,” said Chairman Joyce. “It is no longer sufficient to do the bare minimum. States must rise to the occasion and tackle fraud head-on. Our Medicaid program and the patients that rely on it to be healthy depend on it.”

Watch the full hearing here.

Below are key excerpts from today’s hearing:

image (1).png
Chairman Brett Guthrie (KY-02): “The Committee requested documents and information from your agency on March 3rd, including all audits related to fraud, waste, and abuse in the state’s Medicaid programs—including audits completed by third party contract auditors from January 1, 2021, to present. [...] Based on the information that has been provided to the Committee, we know that California has conducted such audits, but the committee did not receive a single audit document from California until 7 p.m. last night. Do you believe that providing more than 1,300 pages of documents on the eve of a hearing is fair to this committee?” Mr. Sadwith: “Thank you, Chairman... and I acknowledge the frustration.... we have been working with Committee staff to produce information and address the questions, including the list of 26,000 audits and investigations that we have conducted over the past five years. Last night, we provided some audits related to transportation and mental health that the committee had indicated were—” Chairman Guthrie: “There were also other [documents] that we requested... will you commit to providing what we’ve requested to this Committee? In a timely manner?” Mr. Sadwith: “Thank you, Chairman. There are ongoing law enforcement investigations that would be impacted by those specific audits that were requested. We’re happy to provide the appropriate information at the appropriate time.” Chairman Guthrie: “It just seems unfair to us to prepare for a hearing that you send everything to [us at] 7 p.m. last night. It almost seems like that was intentional.”

image (3).png
Congressman Gary Palmer (AL-06): “Mr. Connolly, CMS asks that you revalidate all providers in the 14 high risk Medicaid programs, with nearly 5,600 providers. After the initial revalidation, your office reported it disenrolled more than 3,400 providers; that’s 60 percent of those enrolled. However, last week, it appears your agency restored the billing privileges for over 2,100 that submitted the appeals. What’s going on with this revalidation process, and how are you making sure that providers who are restored pending appeal are filing legitimate claims in the meantime?” Mr. Connolly: “All of those services are subject to enhanced pre-payment review and all of the high-risk designation requirements that are associated with it.” Congressman Palmer: “It’s also been reported that many of the providers that were disenrolled had been flagged by your agency before...in other words, there was some suspicion. Is that true? Had they been flagged before?” Mr. Connolly: “...I’d have to confirm the details of that for you.”

image (2).png
Congressman Michael Rulli (OH-06): “What was exciting for me, Director [Partika], is when I realized that we had the Attorney General and the Auditor working with your office, because, you know what? In life, sometimes we’re not perfect. And the wonderful story about America is that—when you look at our history—we correct our wrongs, like we do in Ohio. We’re not all full of ourselves that we’d say we’re perfect in the state of Ohio, we know that we’re flawed. But I like the idea that the three branches over there—you got the Attorney General’s office, you got the Ohio Auditor, and then you have [the state Medicaid director]—that are all working together to make it better. When you’re fourth in the country for Medicaid expansion, we want to make sure our people have their services.”

Apr 29, 2026

Health

Health Subcommittee Holds Legislative Hearing on Policies to Strengthen FDA Food Regulation

WASHINGTON, D.C. – Today, Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, led a hearing titled Healthier America: Legislative Proposals on the Regulation and Oversight of Food.

“This Administration has taken many steps to help combat the chronic disease epidemic in our country including reforming dietary guidelines, launching operation stork speed, phasing out certain food additives, and much more. For too long, the status quo has remained unchanged,” said Chairman Griffith. “That is why this hearing was an important first step for us to examine what regulatory standards and policies need to be reevaluated.”

Watch the full hearing here.

Below are key excerpts from today’s hearing:

04.29 Joyce.png

Congressman John Joyce, M.D. (PA-13), on H.R. 8414, the Defending Against Imitations and Replacements of Yogurt, Milk, and Cheese to Promote Regular Intake of Dairy Everyday (DAIRY PRIDE) Act: “As kids, we learn probably in about fourth or fifth grade that milk comes from a mammal for the nourishment of their young. Yet, plant-based beverages are being labeled as ‘milk’ and sold in dairy counters across the United States. How can we expect that consumers make nutritious choices when products are being mislabeled right in front of their eyes? My legislation, the DAIRY PRIDE Act, will ensure that dairy products are accurately labeled and will protect consumers from this misleading marketing. The benefits are twofold; the DAIRY PRIDE Act was crafted for consumers and for dairy farmers. Ensuring honest labeling practices both gives the consumers the clarity that they deserve and supports American dairy farmers.”

04.29 Langworthy.png

Congressman Nick Langworthy (NY-23), on H.R. 7366, the Dietary Supplement Regulatory Uniformity Act: “For nearly 30 years, dietary supplements have been regulated under single science-based national framework led by the FDA, giving consumers confidence that products are safe and properly labeled and consistently regulated across the country. But in recent years, as we’ve seen in many different industries, states are moving away from that model, imposing their own arduous requirements and restrictions, often beyond what the FDA has already reviewed and determined to be safe. My state of New York often does this, and it leads to higher costs and fewer choices with consumers. When states override science-based FDA determination, you end up in a situation where the same product is treated as safe in one state, but suspect in another state, just by crossing a state line. That’s regulation for regulation’s sake; it doesn’t make any sense for businesses or the people that they serve. That’s why I have introduced H.R. 7366, the Dietary Supplement Regulatory Uniformity Act, to reaffirm that we should have one clear, science-based national standard—not a patchwork of conflicting state rules.”

04.29 Rulli.png

Congressman Michael Rulli (OH-06), on H.R. 8430, the Third-Party Certification and Inspection Modernization Act of 2026: “I believe, in order to have safe food supply, there must be a robust collaboration between local, state, and federal entities. When I was an Ohio senator, I was impressed on how state regulators ran these such programs. My bipartisan bill, H.R. 8430, would ensure that HHS shares unredacted food safety information with local and state governments. H.R. 8430 will do the following: this bill will allow the FDA to share information, identifying recipients of recalled foods during a food safety incident. I’ve witnessed this personally in my family business for years. This bill also allows FDA to share shipping and distribution information related to a recalled food product. And that's crucial because time is of the essence when you’re doing that. And this bill also requires receiving agencies to keep their information confidential and that it can be shared within the industry.”

Apr 10, 2026

Energy

Chairman Guthrie at CERA Week: Advancing an American Energy Agenda

Recently, Chairman Guthrie joined CERA week in Houston, TX, to discuss the Committee on Energy and Commerce's work to unleash reliable and affordable energy.

The trip provided the opportunity to hear directly from the job creators who are building and operating the energy infrastructure that Americans depend on. The conversations at CERA Week reinforced what’s been said during our hearings: that permitting delays and regulatory uncertainty are holding back the investment we need to support dispatchable, baseload power.

Meeting with industry leaders gave the Chairman the opportunity to discuss the challenges facing our grid in real time, from the lessons of Winter Storm Fern to the energy demand needed to ensure America continues to win the race for AI dominance and onshoring of advanced manufacturing.

The discussion also provided an opportunity to highlight House Republicans’ efforts to reduce energy costs and strengthen grid reliability. Throughout this Congress, Committee members have advanced commonsense legislation to address affordability, reform the permitting process, and prevent the premature retirement of baseload power plants that keep the lights on—around the clock, every day of the year—for millions of Americans.

Streamlining Permitting and Unleashing American Energy

H.R. 1047, the Guaranteeing Reliability through the Interconnection of Dispatchable Power (GRID Power) Act—Rep. Balderson (OH-12)

The GRID Power Act provides Regional Transmission Organizations and Independent System Operators with the authority to prioritize projects in the interconnection queue that improve grid reliability and resiliency. By fortifying our grid with reliable sources of energy such as natural gas, coal, nuclear, and hydropower, we can reduce the risk of blackouts or brownouts and ensure we have the energy needed to meet our power demands.

H.R. 3062, the Promoting Cross-border Energy Infrastructure Act—Rep. Fedorchak (ND-AL)

To secure our nation's energy dominance, House Republicans are fighting to streamline the cross-border permitting process. Establishing a more uniform process to authorize the construction, connection, operation, and maintenance of international border-crossing facilities is vital to supporting the import and export of oil and natural gas as well as the transmission of electricity.

H.R. 3668, the Improving Interagency Coordination for Pipeline Reviews Act—Rep. Hudson (NC-09)

Under current law, the Federal Energy Regulatory Commission (FERC) is designated as the lead agency for coordinating necessary environmental reviews and associated federal authorizations for interstate natural gas pipelines. Unfortunately, pipeline infrastructure approvals are often delayed due to a lack of coordination — or inaction — among states and other federal agencies involved in the process. In 2026, the U.S. Energy Information Administration expects natural gas demand to reach an all-time high. Now more than ever, it is critical we expand our natural gas pipeline capacity to meet that demand.
This legislation modernizes the federal permitting process for interstate natural gas pipelines by bolstering FERC’s role as the lead agency for environmental reviews as the coordinator of Clean Water Act Section 401 water quality reviews. This legislation will help lower energy costs, provide natural gas to power our economy, and strengthen our nation's energy security.-

H.R. 1949, the Unlocking our Domestic LNG Potential Act of 2025—Rep. Pfluger (TX-11)

The U.S. has emerged as the world’s number one producer of oil and natural gas and top exporter of LNG, contributing to domestic energy security, substantial economic benefits, and significant diplomatic leverage abroad. H.R. 1949 amends the Natural Gas Act to repeal all DOE restrictions on the import and export of natural gas, effectively overturning the Biden-Harris Administration's attempt to undermine U.S. domestic energy production.

H.R. 3109, the Researching Efficient Federal Improvements for Necessary Energy Refining (REFINER) Act—Rep. Latta (OH-05)

Refinery expansion is key to lowering costs for Americans, unleashing our abundant energy, and bolstering our energy security. The REFINER Act would help ensure we can produce the reliable oil and gas needed to ensure American energy dominance.

Protecting Baseload Power and Grid Reliability

H.R. 3616, the Reliable Power Act—Rep. Balderson (OH-12)

This legislation addresses the threat of rolling blackouts caused by the Biden-Harris Administration's over reliance on wind and solar power by improving federal rulemaking to ensure that future federal regulations that impact power generation will not harm electric reliability.
The bill amends the Federal Power Act to require FERC review and comment on any federal rules that impact electricity generation during periods of high reliability risks, like the extreme cold we saw this winter, to ensure new rules will not harm electric power reliability.

H.R. 3632, the Power Plant Reliability Act—Rep. Griffith (VA-09)

This legislation enhances existing tools for states and grid operators to contest the closure of power plants in neighboring states if there is an impact to grid reliability. The bill also requires power plants to provide a 5-year notice of any plans to retire.
The states with the highest electricity prices are overwhelmingly the same states with the most aggressive forms of renewable portfolio standards, and this legislation will help to ensure that baseload power plants don't go offline in the places that need them most.

H.R. 3628, the State Planning for Reliability and Affordability Act—Rep. Evans (CO-08)

This legislation would require state Public Utility Commissions to consider requirements for utilities to have sufficient generation from reliable and dispatchable energy sources, such as natural gas, nuclear, coal, and hydropower, over a 10-year period.
The ongoing reliability crisis facing our nation stems from Democrat policies designed to drive out baseload generation in favor of intermittent wind and solar, harming our ability to onshore manufacturing and burdening households with higher costs.
Running a grid on wind and solar is akin to paying for two parallel grids, in part, because these energy sources require backup resources when the wind does not blow or the sun does not shine. Residential ratepayers bear the financial burden of these choices.

H.R. 3015, the National Coal Council Reestablishment Act—Rep. Rulli (OH-06)

Permanently reestablishing the National Coal Council supports the baseload power that can provide abundant, affordable, and reliable energy to communities across the United States.

Securing Supply Chains for America’s Energy Future

H.R. 3638, the Electric Supply Chain Act—Rep. Latta (OH-05)

The bill would direct the Department of Energy to conduct periodic assessments of supply chain constraints or vulnerabilities that could impact the bulk power system.
The Biden-Harris Administration’s misguided energy agenda furthered our reliance on adversarial nations like China for critical materials and manufacturing for wind turbines, solar panels, and grid components that are needed for intermittent generation resources.
As our nation's electric system is under strain from premature retirements of baseload power and historic demand increases due to manufacturing growth and emerging technologies, we must ensure our federal government and policy makers are equipped with the necessary tools to protect the affordability and reliability of the bulk power system.

H.R. 3617, the Securing America’s Critical Minerals Supply Act—Rep. James (MI-10)

This legislation requires the Department of Energy (DOE) to assess critical energy resource supply chains and to strengthen the supply chains that are vulnerable to disruption or overreliance on adversarial nations.
Energy supplies are the linchpin to U.S. global leadership in next generation technologies and industries, job growth in communities across the country, and a robust defense industrial base.
Despite vast domestic natural resources, the United States remains heavily reliant on foreign adversaries for critical energy resources that are essential to our economic and national security. The U.S. is 100 percent reliant on imports for 12 critical minerals and 50 percent import reliant on an additional 28 critical minerals.

The Path Forward

The message from CERA Week was clear, America has the resources to lead the world in energy when burdensome regulations aren’t standing in the way. Chairman Guthrie and the Energy and Commerce Committee will continue advancing legislation that cuts red tape, protects reliable baseload generation, and ensures American families and job creators have access to the affordable, reliable power they need.

Letters

Aug 13, 2026

Health

New HHS Report Depicts How the Working Families Tax Cuts Lowers Health Insurance Premiums and Hospital Prices for Americans

WASHINGTON, D.C. - This week, the U.S. Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation (ASPE) released a report, finding provider tax and state-directed payment policies in the Working Families and Tax Cuts (WFTC) are expected to reduce health care prices by up to 3.5 percent and reduce costs in Medicaid, commercial insurance, and Medicare-noting an additional $29 billion in savings for Medicare and commercial coverage for every $100 billion in Medicaid savings. Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Morgan Griffith (VA-09), Chairman of the Energy and Commerce Subcommittee on Health, issued the following statement in response to ASPE's findings:

"Despite Democrat rhetoric, evidence continues to show that our Working Families Tax Cuts will protect patients by not only restoring the long-term security of the Medicaid program, but also lowering costs for patients. By ending abuses of financing gimmicks, we help save taxpayer dollars and ensure federal funding is being used for the most vulnerable.

"It's no secret that the abuse of provider tax schemes and state directed payment arrangements had become an open-ended checkbook for states to shift more and more costs to the federal government, driving unsustainable and unaccountable growth in the Medicaid program. In a new report released by the Department of Health and Human Services, not only will these policies safeguard the Medicaid program and its beneficiaries but will also lower health care prices by 3.5 percent and reduce health care spending for Americans with private commercial insurance and Medicare. Because of Republicans' commonsense policies, we are protecting our most vulnerable and lowering health care costs for all Americans," said Charimen Guthrie and Griffith

BACKGROUND:

Last year, the House Committee on Energy and Commerce rooted out over a trillion dollars of waste, fraud, and abuse through policies that strengthen, secure, and sustain our Medicaid program.
Health care provider taxes have been used to fund Medicaid supplemental payments like state-directed payments (SDPs), drawing down additional federal Medicaid funding to support higher provider rates without additional expenditures from state general funds.
SDPs increased considerably during the Biden Administration, with managed care organizations receiving $43 billion in payments in 2021-an amount that more than tripled to $144 billion by 2025.
Without the WFTC, payments were expected to exceed $300 billion by 2034.
By 2025, the average service covered by an SDP was compensated at 186 percent of the Medicare rate, meaning often we were paying significantly more to care for able-bodied adults than our seniors.
Policies in the WFTC that reduce the abuse of provider taxes and SDP gimmicks are projected to reduce non-Medicaid prices by up to 3.5 percent, benefiting non-Medicaid payers by $502 billion to $875 billion from 2025-2034.
Once fully phased in, these policies are expected to lower annual health care spending by $100 billion to $175 billion.
Some of the savings to non-Medicaid payers also accrue to the federal government, saving an additional $97 billion to $169 billion beyond its savings on Medicaid and reducing total federal health spending by an average of 2.9 percent to 5.1 percent, when fully phased in.
This isn't just savings for taxpayers; ASPE projects the changes to provider taxes and state directed payments under the WFTC could lead to reduced premiums in commercial insurance markets, making employer-sponsored insurance and Marketplace coverage more affordable for Americans than they would have been without the WFTC.

Read additional coverage on this report HERE.

Aug 5, 2026

Press Release

Chairmen Guthrie and Joyce on the Decertification of Kentucky OPO Following Months of Congressional Oversight

WASHINGTON, D.C. - Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman John Joyce, M.D. (PA-13), Chairman of the Energy and Commerce Subcommittee on Oversight and Investigations, issued the following statements following the Department of Health and Human Services' (HHS) decision to decertify Network for Hope - the Organ Procurement Organization (OPO) covering Kentucky and parts of Ohio, West Virginia, and Indiana.

"Thanks to the steadfast oversight efforts of Secretary Kennedy and our robust oversight on the House Committee on Energy and Commerce, decisive action has been taken to protect American patients and families," said Chairman Guthrie. "We have conducted rigorous oversight of the alarming practices in our organ procurement and transplantation system, and the American people deserve to have an organ procurement and transplantation system that they can trust. This action takes a step forward in restoring integrity back to that system."

"Serious deficiencies in Network for Hope's organ procurement process were brought to light through the work of our Oversight and Investigations Subcommittee," said Chairman John Joyce, M.D. "Despite subsequent efforts by HHS to address these issues, concerns remain about Network for Hope's ability to safely carry out its duties as an OPO. Therefore, I applaud HHS for taking decisive action to initiate the decertification process against the organization. I want to express my gratitude to Secretary Kennedy, Administrator Engels, and Administrator Oz for their attention to this important issue and their recognition of this necessary action following our oversight efforts, including last year's hearing that centered on our concerns regarding Network for Hope. As the process moves forward, I urge Network for Hope to fully cooperate with HHS to ensure that patients and their safety are prioritized throughout the decertification process and the selection of a new OPO to take over Network for Hope's donor service area."

BACKGROUND:

During the 118th Congress, the Committee on Energy and Commerce led the passage of the Securing the U.S. Organ Procurement and Transplantation Network Act to both modernize the Organ Procurement and Transplantation Network (OPTN) and allow HRSA to institute a competitive contracting process to find the best contractors for various OPTN functions. This legislation was signed into law on September 22, 2023.
On March 20, 2024, the Committee launched an investigation into the organ procurement and transplantation system by sending a letter to United Network for Organ Sharing (UNOS) requesting information related to concerns surrounding data security and operability, patient safety and equity, and conflicts of interest.
On March 20, 2024, the Committee also sent a letter to HRSA requesting information related to implementation of the Securing the U.S. Organ Procurement and Transplantation Network Act as well as other concerns related to effective oversight and management.
On September 11, 2024, the Subcommittee on Oversight and Investigations held a hearing that focused on the implementation of reforms at the OPTN, including the need for stronger oversight and accountability as well as ongoing patient safety concerns.
During the hearing, questions were raised related to allegations of mismanagement and patient safety concerns after patients began exhibiting signs of increased neurologic function after being previously deemed suitable as an organ donation candidate. Several of these allegations, particularly those related to patient safety, were later substantiated through the findings contained in HRSA's March 2025 report.
On March 24, 2025, HRSA's Division of Transplantation issued a report that summarized the findings of its investigation into KYDA, the OPO now known as Network for Hope, which serves Kentucky and parts of Ohio, West Virginia, and Indiana.
HRSA's investigation examined an "index case" and an additional 351 unique cases of authorized, not recovered (ANR) patients. This means that the patients were considered for donation after circulatory death recovery, but no organs were transplanted. The report showed that nearly 30 percent of the cases "had concerning features." The concerning features included problems with patient-family interactions, medical assessments and team interactions, recognition of high neurologic function, and recognition and documentation of drugs in records.
On May 28, 2025, HRSA issued a corrective action plan to the OPTN, which directed the OTPN to take specific actions within a specified period of time, including developing a 12-month OPTN monitoring plan for KYDA to address concerns identified. The corrective action plan also requires the OPTN to propose policies for public comment to improve safeguards for potential donation after circulatory death (DCD) patients in the organ procurement process and increase information shared with patient families regarding DCD organ procurement.
On July 22, 2025, the House Committee on Energy and Commerce's Subcommittee on Oversight and Investigations held a hearing examining concerning practices within our nation's organ procurement and transplant system that were identified by HRSA's investigation.
On September 12, 2025, the Committee sent a bipartisan letter to the HRSA requesting a briefing on its ongoing oversight of patient safety in our nation's organ procurement and transplant system.
On November 17, 2025, Chairmen Guthrie and Joyce sent a letter to CMS requesting a briefing to better understand HHS' recent actions and ongoing work to enhance safety within the organ procurement and transplantation system.

Jul 29, 2026

Press Release

Congressional Leaders Get Answers from CBO on Unbudgeted IRA Costs and Multibillion-Dollar Spending Revisions

WASHINGTON, D.C. - Today, the Congressional Budget Office (CBO) responded to a May 20, 2026 letter, authored by Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Jason Smith (MO-08), Chairman of the House Committee on Ways and Means, and Congressman Jodey Arrington (TX-19), Chairman of the House Committee on the Budget, seeking further explanation for CBO's dramatic upward revision of Medicare Part D spending. Chairmen Guthrie, Smith, and Arrington issued the following statements in response to CBO's findings:

"Earlier this year, CBO's baseline update projected significantly higher costs for Medicare Part D, including an estimated $700 billion in additional Medicare prescription drug spending over the next decade," said Chairman Guthrie. "In response to the May letter I sent, alongside Chairmen Arrington and Smith, CBO highlighted how the problematic design of the Inflation Reduction Act (IRA) has not led to the savings CBO originally projected but has instead led to increased costs for taxpayers and instability in the Part D marketplace. The Part D program is critical to meeting seniors' needs and requires durable regulatory policies to ensure the long-term affordability and availability of prescription drug plans for these beneficiaries."

"Washington Democrats' Inflation Expansion Act was yet another costly promise that failed to deliver lower prices for seniors. Democrats promised lower prescription drug prices, but the Congressional Budget Office is once again confirming that their policies instead increased costs for America's seniors and taxpayers by an additional $700 billion while offering 50% fewer drug plans for them to choose from. Plain and simple, Democrats have made it harder for seniors to afford prescription drugs," said Chairman Smith. "Because of these misguided policies, Americans are paying more for health care than ever before while facing fewer choices and less access to care in return. Meanwhile, powerful health care empires continue to benefit from government-created distortions, loopholes, and misaligned incentives that reward higher spending instead of better outcomes. The Ways and Means Committee will continue fighting to hold these empires accountable, expand access to care, and lower costs - not help powerful interests that have benefited from the status quo."

"The Congressional Budget Office's (CBO) new analysis confirms what Republicans sounded the alarm on for years: The drug pricing scheme in the Inflation Reduction Act fails to deliver the savings Democrats promised. CBO originally estimated these policies would save taxpayers $129 billion. Instead, CBO now confirms the IRA's misguided policies were the major driver behind higher projected Part D expenditures, contributing to a $700 billion deficit increase," said Chairman Arrington. "We have once again confirmed that Democrats, with CBO's analysis in hand, sold the American people a false bill of goods in the Inflation Reduction Act. Combined with the Joint Committee on Taxation's $600 billion miscalculation of the cost of the Green New Deal tax credits, we now know the IRA cost Americans $1.3 trillion more in new deficit spending. Today, taxpayers are left holding the bag due to Democrats' failed experiment in price fixing and their green new deal climate agenda."

BACKGROUND:

On May 20, 2026, Chairmen Guthrie, Smith, and Arrington penned a letter to CBO regarding its updated scoring of the IRA and updated Part D outlay projections.
This revision includes an approximately $700 billion increase in projected Medicare Part D outlays and shows that Part D spending per beneficiary in 2035 is now projected to be more than $4,000.
The Government Accountability Office (GAO) confirmed that the Biden-Harris administration's "Premium Stabilization Demonstration" under Medicare spent $9.8 billion on premium stabilization.
On July 28, 2026, the Centers for Medicare & Medicaid Services announced the conclusion of the Part D Premium Stabilization Demonstration, discontinuing the demonstration at the end of CY 2026 to return the program to operating under traditional market conditions in CY 2027.
On July 29, 2026, CBO responded to the Congressional leaders' inquiry, providing additional information on CBO's original estimates and current projections of the drug pricing provisions enacted in the IRA, as well as projections about Part D spending growth in the next decade.
According to the Medicare Payment Advisory Commission (MedPAC), the average number of stand-alone prescription drug plans available to beneficiaries in 2025 was 14, the lowest number since Part D began.
MedPAC has also noted a decline in recent years in the average number of benchmark plans, which are $0 premium plan options for beneficiaries receiving the low-income subsidy.